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Background: Data is sparse concerning the magnitude of metabolic syndrome (MetS) in developing countries
like Ethiopia whose major health problem had long been under-nutrition and infectious diseases rather than
non-communicable diseases (NCDs) including hypertension, obesity and MetS. However, it is obvious that the
NCDs are recently taking over and becoming the major health care concerns in the developing countries. This
pattern could be partly explained by the nation’s sustained economical growth in the last few decades in addition
to the increasing globalization related adoption of western lifestyle. The aim of this study was to assess the
prevalence of metabolic syndrome and associated factors among hypertensive patients in North West Ethiopia.
Method: A cross sectional study was conducted on 300 hypertensive individuals who get follow-up care at
University of Gondar Hospital after diagnosed as hypertensive. The WHO STEP-wise approach to surveillance of NCD
was used. Fasting blood glucose level, triglyceride and high density lipoprotein cholesterol were determined using
standardized laboratory procedures.
Result: The prevalence of metabolic syndrome was 40.7% and 39.3% according to the modified NCEP-ATP III and
IDF criteria respectively. Low HDL-c was found to be the most frequently encountered (81.3%) component of MetS
other than the hypertension. Being female was significantly associated with MetS (AOR = 4.34; 95% CI: 2.09, 8.99)
using IDF and (AOR = 3.30; 95% CI: 1.66, 6.58) using NCEP-ATP III criteria. Abnormal BMI which included both high
and low BMI was found to have significant association with MetS (AOR = 3.10; 95% CI: 1.73, 5.58) using IDF and
(AOR = 1.84; 95% CI: 1.05, 3.22) as diagnosed using the NCEP-ATP III criteria.
Conclusion: We recommend a comprehensive medical care approach to hypertensive patients to adequately
assess and address the additional components of MetS which are known to potentiate the risks of cardiovascular
diseases among hypertensive patients.
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Hypertension and Metabolic syndrome (MetS) are highly
prevalent diseases that present a global challenge [1,2]. In
2000, approximately 1 billion people worldwide (26.4% of
the adult population) were estimated to have hypertension
and this is likely to increase to over 1.5 billion by 2025 as
a result of aging population in many developed countries,
and an increasing incidence of hypertension in developing* Correspondence: hakimulig@gmail.com
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article, unless otherwise stated.countries [2]. In Ethiopia the prevalence of hypertension is
estimated to be 35.2% [3]. It is also estimated that around
20-25% of the world’s adult population has metabolic syn-
drome and they are twice as likely to die from it; and they
are three times more likely to have a heart attack or stroke
compared with people without the syndrome [3,4].
When hypertension and MetS components co-exist in
an individual they potentiate one another leading to syner-
gism that increase the total CVD risk [5]. Hypertension is
one of the major manifestations of the group of clinical
abnormalities that characterize metabolic syndrome found
in 30 to 40% of hypertensive individuals [6]. Use of sometral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ing agents may worsen insulin resistance and increase the
risk of developing cardiovascular disease [7].
Even though there are different studies done on the
prevalence of metabolic syndrome in different parts of
the world [7-10], data regarding the situation in Africa
especially Ethiopia is very sparse; and even the few re-
ports on MetS in the area are not specifically done
among hypertensive individuals [11,12]. To the best of
our knowledge, there are no reports on the prevalence
of metabolic syndrome among hypertensive patients in
Ethiopia particularly in the study area. Hence, the aim of
this study was to determine the prevalence of metabolic
syndrome among hypertensive patients and assess the
associated factors.
Methods
Study setting and study population
This study was conducted in the University of Gondar
hospital, from July 1 to August 31, 2013. The hospital
has more than 500 beds capacity and serves as a tertiary
level referral center for over five million people in and
around Gondar town. This cross sectional study was
conducted among hypertensive patients having follow-
up care at the hypertension clinic of the hospital which
is scheduled as a day weekly service at chronic illness
clinic.
Sample size and sampling technique
The sample size was estimated based on single population
proportion formula using a confidence interval (CI) of
95% and a 31.2% previous prevalence of metabolic syn-







Where, n = sample size, p = proportion of hypertensive
patients who may have metabolic syndrome and d = as-
sumed marginal error. Based on the above formula and
assumptions, the sample size was calculated to be 300.
Then, every third participants were selected using sys-
tematic random sampling technique. There were a total
of 3000 registered hypertension patients attending the
clinic with an average follow-up interval of 2-3 month.
All participants were with the age of greater than or
equal to 18 years.
Data collection
Data on the characteristics of study participants
The socio-demographic, behavioral, physical and clinical
characteristics of the study participants were collected
using an interview based structured questionnaire adopted
from the WHO STEPS manual that was prepared for thispurpose [14]. Data that were not captured by the interview
were completed by assessing the medical records of the
patients.
Anthropometric and blood pressure measurement
Anthropometric data (weight, height and waist circumfer-
ence) were collected according to WHO STEPS manual
[14]. Height was measured using stadiometer and weight
was recorded after measuring the patient bare footed and
wearing light clothes using a weight balance. During the
height measurement, the participant’s shoes and any hats
or hair ornaments were removed. The subject faces away
from the wall with the heels together and the back as
straight as possible. The head, shoulders, buttocks, and
heels should be in contact with the vertical surface. With
the subject looking straight ahead, the head projection is
placed at the crown of the head. The participant steps
away from the wall and the height measurement is re-
corded to the nearest 0.1 cm. From weight and height
measurements, body mass index was calculated. Waist cir-
cumference (in centimeter) was measured at the midpoint
between the lowermost rib and the iliac crest.
Blood pressure (BP) was measured using a standard
adult arm cuff of mercury type sphygmomanometer after
10 min rest in the clinic by the nurses working in the
chronic diseases follow up clinic. To improve the reliabil-
ity of measurement two readings were taken with 1 min
interval and the average of the two readings was recorded
as the final BP of the patient. But if the difference between
the two readings was greater than 5 mmHg, a third meas-
urement was taken and the average of the three readings
was recorded as the final BP of the patient [15].
Laboratory investigation
Five milliliter of venous blood was collected from each
patient in plane test tubes and serum was separated im-
mediately. The extracted serum was investigated for
High density lipoprotein-cholesterol (HDL-c), triglycer-
ide and fasting glucose using Mindray BS-200 chemistry
analyzer (Shenzen Mindray Bio-Medical electronics Co.
Ltd) according to manufacturer’s instructions.
Triglycerides was determined by enzymatic hydrolysis
with lipase (Human Gesellschaft fur Biochemica und
Diagnostica mbH, Germany), HDL-c was determined by
specific enzymatic method after eliminating chylomi-
crons, very low density lipoproteins and low density
lipoproteins (Human Gesellschaft fur Biochemica und
Diagnostica mbH, Germany) and glucose was determined
by glucose oxidase method (LINEAR CHEMICALS S.L.,
Barcelona).
Definition of metabolic syndrome
Metabolic syndrome was defined according to modified
NCEP-ATP III and IDF criteria.
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In accordance with the IDF criteria, subjects were classi-
fied as having MetS if participants had abdominal obes-
ity (defined as waist circumference of ≥94 cm for men
and ≥80 cm women) plus two of any of the following
risk factors: (1) raised TG level (≥150 mg/dL); (2) re-
duced HDLC (<40 mg/dL in males and <50 mg/dL in
females); (3) raised blood pressure (systolic BP ≥130 or
diastolic BP ≥85 mmHg) or treatment of previously di-
agnosed hypertension; (4) raised FG (≥100 mg/dL) [16].
Modified NCEP-ATP III definition
In accordance with the ATP III criteria, subjects were clas-
sified as having MetS if participants had three or more of
the following risk factors: (1) abdominal obesity (waist cir-
cumference >102 cm in males and >88 cm in females); (2)
hypertriglyceridemia (TG ≥150 mg/dL); (3) reduced HDL-
c (<40 mg/dL in males and <50 mg/dL in females); (4)
high BP (≥130/85 mmHg); (5) FG (≥100 mg/dL) [17].
Data analysis
Data was entered into EPI INFO computer software and
exported to SPSS version 16 for analysis. Frequency distri-
butions of socio-demographical, clinical and behavioral
characteristics of subjects were explored. Continuous vari-
ables were expressed as mean ± standard deviation or me-
dian (inter quartile range) and categorical variables were
expressed as number (percentage). Univariate and multi-
variate binary logistic regression analysis was used to
evaluate the differences in the distribution of categorical
variables for study groups. P-value < 0.2 was used as a cut-
off to include variables for multivariate binary logistic re-
gression model. Student’s t-tests was used to evaluate
differences in mean for study groups. The prevalence esti-
mates for metabolic syndrome according to the two defi-
nitions was determined separately. In all cases P-values <
0.05 at 95% confidence level was considered statistically
significant.
Data quality control
Trained nurses working in the chronic diseases follow up
clinic were involved in the collection of socio-demographic,
behavioral, clinical and physical characteristics from the pa-
tients. The proper functioning of instruments, laboratory
reagents, and technical performance was checked by using
quality control samples. Standard operating procedures
(SOPs) were followed starting from sample collection up to
result reporting. All laboratory procedures were handled by
laboratory technologists.
Ethical considerations
Ethical clearance was obtained from School of Biomed-
ical and Laboratory Sciences, University of Gondar. Be-
fore enrolling any of the eligible study participants; thepurpose, benefits and risk of the study was clarified and
discussed for each participant. Data was collected after
informed consent was obtained and confidentiality of
the information was kept by using codes. The results of
the participants were communicated with the clinicians
for better management of the patients.
Results
Sociodemographic and behavioral characteristics of the
study participants
A total of 300 (115 male and 185 female) hypertensive
patients, with a mean (±SD) age of 54 (±14) years, par-
ticipated in this study. Majority, 78.3%, 56%, 41% of the
study participants were urban dwellers, married and
educationally unable to read and write respectively. Only
8.3% of the study participants had alcoholic drink at
least once in the previous year and only 1% of the partic-
ipants had a history of smoking. Palm oil was used by
55% of the study participants to prepare food. The 21.7%
of the study participants had a day to day working habit
full of vigorous intensity of activities which includes
farming; long distance walking, laborious activities. Only
6% of the study participants have history of performing a
purposely planned regular physical exercise (Table 1).
Clinical features, biochemical values and physical
characteristics of the study participants
From the study participants 21% reported family history of
one or more of the chronic diseases (hypertension, dia-
betes mellitus and/or cardiac problem) and 94.7% started
antihypertensive drug therapy. Among the patients who
started treatment 42% were taking at least two types of
antihypertensive drugs. The median (IQR) time since the
initiation of treatment was 2 (0.4-4) years for men and 2
(0.5-6) years for women. Abnormal body mass index,
which in this study includes both high and low BMI, was
observed among 40% (121/300) of the study participants;
women (45.4%) being more frequently affected as compared
to their male (32.2%) counterparts. Women also showed
higher mean concentrations of glucose (93.3 mg/dl) and
HDL cholesterol (37.8 mg/dl). The median triglyceride
values were 107 mg/dl for men and 115 mg/dl for women
(Table 2).
Prevalence of metabolic syndrome and frequency of
metabolic syndrome components
The prevalence of metabolic syndrome was calculated
based on the two criteria. According to the modified
NCEP-ATP III criteria the overall prevalence of metabolic
syndrome was 40.7%, women having high rate of meta-
bolic syndrome, 46.5%, as compared to men, 31.3%. A
relatively similar result was also obtained using the IDF
criteria. Based on the IDF criteria 125 (41.7%) hypertensive
patients had abdominal obesity among whom 118 (94.4%)
Table 1 Sociodemographic and behavioral characteristics
of the hypertensive patients at University of Gondar
Hospital, July 1-August 31/2013
Variable Men (115) Women (185) P-value
N (%) N (%)
Age
< 30 9 (7.8) 11 (5.9) 0.001
30-50 30 (26.1) 88 (47.6)
≥51 76 (66.1) 86 (46.5)
Residence
Urban 85 (73.9) 150 (81) 0.143
Rural 30 (26.1) 35 (18.9)
Educational Status
Unable to read and write 28 (24.3) 96 (51.9) <0.001
Primary school 44 (38.3%) 44 (23.8%)
Secondary school and above 43 (37.4%) 45 (24.3%)
Marital Status
Single 14 (12.2) 13 (7) <0.001
Married 96 (83.5) 72 (38.9)
Divorced 1 (0.87) 35 (19)
Widowed 4 (3.5) 65 (35.1)
Occupation
Government employee 24 (20.9) 27 (14.6) <0.001
Unemployed 36 (31.3) 122 (65.9)
Self employee 55 (47.8) 36 (19.5)
Monthly income (in ETB)‡
≤ 600 61 (53.0) 121 (65.4) 0.048
601-1500 35 (30.4) 48 (25.9)
≥1501 19 (16.5) 16 (8.6)
Oil used in food preparation
Palm oil 76 (66.1) 89 (48.1) 0.002
Cereal oil 39 (33.9) 96 (51.9)
Work involving vigorous intensity
of activity£
Yes 30 (26.1) 35 (18.9) 0.143
No 85 (73.9) 150 (81.1)
Regular physical exercise*
Yes 10 (8.7) 8 (4.3) 0.121
No 105 (91.3) 177 (95.7)
‡ETB = Ethiopian birr, is the formal currency of the country;
£Participants who daily walks for over one hour to go to work, or participants
who are farmers or day laborers whose work doesn’t predominantly
involve sitting;
*Participants who purposefully made any kind physical exercise for over thirty
minute three times a week.
Table 2 Clinical features, biochemical values and physical
characteristics of hypertensive patients at University of






n (%) n (%)
Family history of chronic diseases
Yes 23 (20) 40 (21.6) 0.74
No 92 (80) 145 (78.4)
Duration since hypertension
diagnosis
< 1 year 42 (36.5) 67 (36.2) 0.257
1-5 years 49 (42.6) 65 (35.1)
≥6 years 24 (20.9) 53 (28.8)
Anti-hypertensive treatment
started
Yes 110 (95.7) 174 (94.1) 0.549
No 5 (4.3) 11 (5.9)
Duration since anti-hypertensive
started
< 1 year 43 (39.1) 78 (44.8) 0.029
1-5 years 49 (44.5) 52 (29.9)
≥6 years 18 (16.4) 44 (25.3)
Combination of hypertensive
drugs
0 5 (4.3) 11 (5.9) 0.435
1 44 (38.3) 83 (44.9)
2 52 (45.2) 73 (39.5)
3 14 (12.2) 18 (9.7)
Body mass index (Kg/m2)
Normal 78 (67.8) 101 (54.6) 0.023
Abnormal£ 37 (32.2) 84 (45.4)
Mean (SD) Mean (SD)
Systolic blood pressure (mmHg) 134.7 (20.4) 136.6 (21.5) 0.866
Diastolic blood pressure (mmHg) 83.5 (11) 83.4 (11.6) 0.465
Glucose (mg/dl) 87.1 (20.4) 93.3 (28.1) 0.044
HDL cholesterol (mg/dl) 31.9 (12.2) 37.8 (12.5) <0.001
Waist circumference (cm) 85.9 (11.2) 80.99 (12.6) <0.01
Median (IQR) Median (IQR)
Triglyceride (mg/dl) 107 (73, 134) 115 (83, 163) 0.0635*
*Data are median (inter-quartile range) since distribution was skewed, and test
of significance was based on log-transformed values;
£Both high and low body mass index was merged together as abnormal BMI
for analysis purpose.
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Hence, the overall prevalence of MetS according to the
IDF criteria was 39.3%; 24.3% among men and 48.6%among women. The frequency of metabolic syndrome
components, other than the hypertension, according to
the modified NCEP-ATP III criteria was 18.7%, 25.3%,
27.3% and 81.3% for abdominal obesity, elevated fasting
glucose, elevated triglyceride and reduced HDL-c respect-
ively. Higher prevalence of abdominal obesity and reduced
Table 3 Frequency of metabolic syndrome (MetS) components other than elevated blood pressure (HTN) among
hypertensive patients at University of Gondar Hospital, July 1- August 31/2013
MetS component other than HTN Overall frequency N = 300; n (%) Men N = 115; n (%) Women N = 185; n (%) P-value
Abdominal obesity by NCEP-ATP III 56 (18.7) 9 (7.8) 47 (25.4) <0.001
Abdominal obesity by IDF 125 (58.3) 29 (25.2) 96 (51.9) <0.001
Elevated fasting glucose 76 (25.3) 23 (20) 53 (28.6) 0.094
Elevated triglyceride 82 (27.3) 26 (22.6) 56 (30.3) 0.148
Reduced HDL-c 244 (81.3) 86 (74.8) 158 (85.4) 0.022
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values were similar applying IDF criteria except for ab-
dominal obesity which the prevalence was 58.3% with sig-
nificantly higher values among women (51.9%) compared
to men (25.2%) (Table 3).
According to the modified NCEP-ATP III criteria 53%
men and 51.9% women had one additional metabolic
syndrome component other than hypertension. Using
the IDF criteria 43.5% of men and 34.6% of women had
one additional MetS component other than elevated
blood pressure (Table 4). The IDF criteria also showed
that 13.9% men and 22.2% women had two metabolic
syndrome components in addition to abdominal obesity.
Factors associated with prevalence of metabolic
syndrome
According to the modified NCEP-ATP III criteria being
female (COR = 1.91; 95% CI: 1.17, 3.12), being a govern-
ment employees (COR = 3.60; 95% CI: 1.76, 7.39), being
unable to read and write (COR = 0.36; 95% CI: 0.21,
0.64), having a monthly income of 601-1500 Ethiopian
birr (COR = 1.84; 95% CI: 1.09, 3.13), having abnormal
BMI (COR = 2.97; 95% CI: 1.84, 4.80) and using palm
oil for food preparation (COR = 0.54; 95% CI: 0.34,0.86)
were found to be significantly associated with the devel-
opment of MetS. However, on the multivariate analysis
the association was maintained for being female (AOR =
3.30; 95%CI: 1.66, 6.58), being unable to read and write
(AOR = 0.30; 95%CI: 1.66, 6.58) and abnormal BMITable 4 Number of metabolic syndrome (MetS)
components other than elevated blood pressure (HTN) by
Gender according to the modified NCEP-ATP III criteria
and the IDF criteria at University of Gondar Hospital, July
1- August 31/2013






Men Women Men Women
0 15.7 32 14.8 3.2
1 53 51.9 43.5 34.6
2 23.5 24.3 28.7 34.1
3 6.1 1.8 10.4 18.9
4 17.3 4.3 2.6 9.2(AOR = 1.84; 95% CI: 1.05, 3.22). Additionally, some
variables that didn’t show significant association on the
univariate analysis such as duration since hypertension
diagnosis 1-5 years (AOR = 0.21; 95% CI: 0.06, 0.71), dur-
ation since hypertension diagnosis >5 years (AOR = 0.16;
95%CI: 0.03, 0.86), duration since on anti-hypertensive
therapy 1-5 years (AOR = 5.04; 95% CI: 1.56, 16.33) and
duration of anti-hypertensive therapy >5 years (AOR =
6.73; 95% CI: 1.26-36.00) were found to have significant
association (Table 5).
Similarly, applying the IDF criteria for MetS, the uni-
variate analysis showed that being female (COR = 3.01;
95% CI: 1.80, 5.03), being a government employees
(COR = 2.96; 95% CI: 1.42, 6.18), having abnormal BMI
(COR = 4.40; 95% CI: 2.68, 7.21), having an educational
status of less than primary school (COR = 0.38; 95% CI:
0.21, 0.71), living in the rural area (COR = 0 .27; 95% CI:
0.14, 0.53), duration since hypertension diagnosis > 5
years (COR = 2.51; 95% CI: 1.37, 4.60) and duration
since ant-hypertensive therapy > 5 years (COR = 2.24;
95% CI: 1.20, 4.20) were found to be significantly associ-
ated with the development of MetS. However, the multi-
variate analysis showed that being female (AOR = 4.34;
95% CI: 2.09, 8.99), having an educational status of pri-
mary school (AOR = 0.40; 95% CI: 0.17, 0.93), being un-
able to read and write (AOR = 0.39; 95% CI: 0.15, 1.02)
and abnormal BMI (AOR = 3.10; 95% CI: 1.73, 5.58)
have maintained the significant association with MetS
(Table 6).Discussion
This study showed high prevalence of metabolic syn-
drome among hypertensive patients attending followup at
University of Gondar Hospital. Using the modified NCEP-
ATP III criteria the prevalence of metabolic syndrome was
found to be 40.7% which is relatively similar to the preva-
lence obtained according to the IDF criteria (39.3%).
Moreover, females were found to have a higher prevalence
of metabolic syndrome (NCEP-ATP III = 46.5%; IDF =
48.6%) as compared to men (NCEP-ATP III = 31.3%;
IDF = 24.3%). Though not statistically significant, in-
creased occurrence of metabolic syndrome was also ob-
served in the subjects aged ≥50 years.
Table 5 Factors associated with metabolic syndrome (MetS) according to the modified NCEP-ATP III criteria among
hypertensive patients at University of Gondar Hospital, July 1- August 31/2013





N (%) N (%)
Sex
Male 36 (12.0) 79 (26.3) 1 1
Female 86 (28.7) 99 (33.0) 1.91 (1.17,3.12) < 0.01 3.30 (1.66, 6.58) 0.001
Age
< 30 6 (2.0) 14 (4.7) 1
30-50 59 (19.7) 59 (19.7) 2.33 (0.84, 6.49) 0.10 1.94(0.60, 6.27) 0.27
≥51 57 (19.0) 105 (35.0) 1.27 (0.46, 3.48) 0.65 2.10(0.62, 7.12) 0.24
Educational status
Unable to read and write 40 (13.3) 84 (28.0) 0.36 (0.21, 0.64) <0.001 0.30 (0.12, 0.74) 0.01
Primary schools 32 (10.7) 56 (18.7) 0.43 (0.24, 0.80) <0.01 0.55 (0.25, 1.21) 0.14
Secondary school or more 50 (16.7) 38 (12.7) 1 1
Occupation
Government employee 32 (10.7) 19 (6.3) 3.60 (1.76, 7.39) < 0.001 2.14 (0.84, 5.45) 0.11
Unemployed 61 (20.3) 97 (32.3) 1.34 (0.78, 2.32) 0.29 0.96 (0.49, 1.85) 0.89
Self employed 29 (9.7) 62 (20.7) 1 1
Monthly income in ETB‡
≤ 600 63 (21.0) 119 (39.7) 1 1
601-1500 41 (13.7) 42 (14.0) 1.84 (1.09, 3.13) 0.02 0.72 (0.28, 1.88) 0.51
≥1501 18 (6.0) 17 (5.7) 2.00 (0.96, 4.15) 0.06 0.93 (0.35, 2.42) 0.88
Oil used in food preparation
Palm oil 56 (18.7) 109 (36.3) 0.54 (0.34, 0.86) <0.01 0.61 (0.36, 1.06) 0.08
Cereal oil 66 (22.0) 69 (23.0) 1
Regular physical exercise*
Yes 10 (3.3) 8 (2.7) 1
No 112 (37.3) 170 (56.7) 0.53(0.20, 1.38) 0.19 2.15 (0.68, 6.86) 0.20
Duration since hypertension diagnosis
< 1 year 38 (12.7) 71 (23.7) 1
1-5 years 47 (15.7) 67 (23.3) 1.31 (0.76, 2.26) 0.33 0.21 (0.06, 0.71) 0.01
≥6 years 37 (12.3) 40 (13.3) 1.73 (0.95, 3.14) 0.07 0.16 (0.03, 0.86) 0.03
Duration since anti-hypertensive started
< 1 year 43 (15.1) 78 (27.5) 1
1-5 years 45 (15.8) 56 (19.7) 1.55 (0.85, 2.50) 0.17 5.04 (1.56, 16.33) 0.01
≥6 years 31 (10.9) 31 (10.9) 1.81 (0.97, 3.39) 0.06 6.73 (1.26, 36.00) 0.03
Body Mass Index (BMI)
Normal 54 (18.0) 125 (41.7) 1 1
Abnormal£ 68 (22.7) 53 (17.7) 2.97 (1.84, 4.80) <0.001 1.84 (1.05, 3.22) 0.03
‡ETB = Ethiopian birr, is the formal currency of the country; COR = crude odds ratio; AOR = adjusted odds ratio; CI = confidence interval.
*Participants who purposefully made any kind physical exercise for over thirty minute three times a week;
£Both high and low body mass index was merged together as abnormal BMI for analysis purpose;
P-value < 0.2 was used to include the variables for adjusting in the multivariate binary logistic regression.
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drome prevalence of 31.2% among newly diagnosed hyper-
tensive patients according to the NCEP-ATP III criteria
and a study from Kuwait reported a prevalence of 34%[5,9]. These reports are slightly lower than the finding in
our study; this might be explained by the fact that the
Nigerian study included only newly diagnosed hyperten-
sive patients who didn’t start anti-hypertensive treatment.
Table 6 Factors associated with metabolic syndrome (MetS) according to the IDF criteria among hypertensive patients
at University of Gondar Hospital, July 1- August 31/2013
Variables MetS No MetS Crude OR (95% CI) P-value Adjusted OR (95% CI) P-value
Sex
Male 28 (9.3) 87 (29) 1 1
Female 91(30.3) 94 (31.3) 3.01 (1.80, 5.03) <0.001 4.34(2.09, 8.99) <0.001
Age
<30 5 (1.7) 15 (5) 1
30-50 50 (16.7) 68(22.7) 2.21 (0.75, 6.47) 0.15 0.74(0.20, 2.71) 0.65
>51 64 (21.3) 98 (32.7) 1.96 (0.68, 5.66) 0.21 1.27(0.34, 4.77) 0.73
Residence
Urban 107 (35.7) 128 (42.7) 1
Rural 12 (4) 53 (17.7) 0.27 (0.14, 0.53) <0.001 0.60(0.25, 1.42) 0.24
Educational status
Unable to read and write 47 (15.7) 77 (25.7) 0.56(0.32, 0.97) 0.04 0.39(0.15, 1.02) 0.05
Primary schools 26 (8.7) 62 (20.7) 0.38 (0.21, 0.71) 0.02 0.40(0.17, 0.93) 0.03
Secondary school or more 46 (15.3) 42 (14) 1 1
Occupation
Government employee 24 (8) 27 (9) 2.96 (1.42, 6.18) 0.004 1.10(0.41, 2.91) 0.85
Unemployed 74 (24.7) 84 (28) 2.94 (1.65, 5.24) <0.001 1.64(0.78, 3.43) 0.19
Self employed 21 (7) 70 (23.3) 1 1
Monthly income in ETB‡
≤ 600 66 (22) 116 (38.7) 1
601-1500 39(13) 44 (14.7) 1.56 (0.92, 2.64) 0.10 1.57(0.81, 3.06) 0.19
≥1501 14 (4.7) 21 (7) 1.17 (0.56, 2.46) 0.68 1.16(0.40, 3.34) 0.79
Oil used in food preparation 1
Palm oil 59 (19.7) 106 (35.3) 0.70(0.44, 1.11) 0.13 0.88(0.49, 1.56) 0.66
Cereal oil 60 (20) 75 (25) 1 1
Duration since hypertension diagnosis
< 1 year 34 (11.3) 75 (25) 1 1
1-5 years 44 (14.7) 70 (23.3) 1.39 (0.80, 2.41) 0.25 0.59(0.19, 1.82) 0.36
≥6 years 41 (13.7) 36 (12) 2.51 (1.37, 4.60) 0.003 1.36(0.29, 6.32) 0.70
Duration since anti-hypertensive started
< 1 year 39 (13.7) 82 (28.9) 1 1
1-5 years 43 (15.1) 58 (20.4) 1.56(0.90, 2.70) 0.11 2.45(0.83, 7.23) 0.10
≥6 years 32 (11.3) 30 (10.6) 2.24 (1.20, 4.20) 0.01 1.11(0.24, 5.21) 0.90
Body Mass Index (BMI)
Normal 46 (15.3) 133 (44.3) 1 1
Abnormal£ 73 (24.3) 48 (16) 4.40(2.68, 7.21) <0.001 3.10(1.73, 5.58) <0.001
‡ETB = Ethiopian birr, is the formal currency of the country; COR = crude odds ratio; AOR = adjusted odds ratio; CI = confidence interval.
£Both high and low body mass index was merged together as abnormal BMI for analysis purpose;
P-value < 0.2 was used to include the variables for adjusting in the multivariate binary logistic regression.
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when compared to a study that includes chronically hy-
pertensive patients. Moreover, there could be socio-
demographic, lifestyle and genetic differences between our
population and the population of Kuwait. On the other
hand, slightly higher and lower prevalence of MetS wasreported from Nigeria (45.6%), Taiwan (31.3%), and other
parts of the world [13,18-20]. And, these reports are
comparable to our study.
The frequency of metabolic syndrome components in
this study was 18.7%, 25.3%, 27.3% and 81.3% for abdom-
inal obesity, elevated fasting glucose, elevated triglyceride
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for reduced HDL-c, were lower than a study conducted in
Jordan [20]. This might be explained by the difference in
lifestyle and socioeconomic status of the two populations
which is reflected by high rates (86.1%) of obese individ-
uals in the Jordan study. In the contrary, the report in the
current study was higher than a study conducted in
Nigeria that showed the percentage of individuals with
MetS were, 40.4% for men and 38.9% for women accord-
ing to the modified NCEP-ATP III criteria [5]. This may
be due to the fact that only newly diagnosed individuals
were included in the Nigerian study.
Concordant to our finding, the association between
sex and metabolic syndrome was reported in other stud-
ies [7,21]. Individuals with abnormal BMI were found to
have a significant association with MetS as compared to
those with normal BMI. In this study both low and high
BMI values were merged as abnormal BMI for the pur-
pose of analysis. Literatures are now coming out indicat-
ing that low BMI and malnutrition may contribute to
low HDL-c; [22] high BMI is known to be associated
with low HDL-c and high waist circumference, a cumu-
lative effect of which could lead to high prevalence of
MetS among individuals with abnormally high or low
BMI [22]. The NCEP-ATP III criteria showed significant
association between the occurrence of MetS and the
duration since hypertension diagnosis and treatment.
This could be partly explained by the possibility of hav-
ing more components of MetS in a chronically hyperten-
sive patient compared to the newly diagnosed ones.
Moreover, though specific anti-hypertensive drug type
stratification and analysis was not done, it may indicate
that some of the antihypertensive drugs like diuretics or
β-adrenergic blocking agents could contribute to insulin
resistance and hence to higher rates of MetS [7].
Our study has indicated that having an educational
status of less than of less than primary school level has
significant association with the occurrence of Mets. This
could be explained by the fact that the lifestyle, type of
work and even place of residence could be affected by
the level of education which may also indirectly impact
the risk and occurrence of MetS. This could also partly
explain the effect of income on the occurrence of MetS.
Studies from Nigeria [5] and Kuwait [9] indicated the
presence of an association between the age of hyperten-
sive patients and metabolic syndrome prevalence. How-
ever in the current study age didn’t show any statistically
significant association. This may be due to the inclusion
of highly susceptible study subjects in the Kuwait and
Nigerian studies.
Due to the cross sectional nature of the study, tem-
poral relations could not be established between meta-
bolic syndrome and the associated factors. Moreover,
only two definitions were used to assess the prevalenceof MetS; a different prevalence rate could have been ob-
served if other metabolic syndrome definition like the
WHO definition were used. Despite these limitations
this study ultimately adds to the limited data on meta-
bolic syndrome in sub-Saharan Africa, particularly in the
study area.Conclusion
The prevalence of metabolic syndrome among hyperten-
sive patients is high, with low HDL-c being the most com-
monly encountered abnormality. Being female, having
abnormally high or low BMI and having less than primary
school educational status were found to have significant
association with the occurrence of MetS. Majority of the
hypertensive individuals were at a high risk of developing
MetS as they have one more very common additional risk
factor (low HDL-c). Therefore, all hypertensive patients
should be aggressively screened for the presence of add-
itional cardiovascular risk factors that constitute the meta-
bolic syndrome. Management of hypertensive patients in
the presence of an additional component of metabolic
syndrome should be comprehensive enough to address
the increased risk of cardiovascular and diabetes related
events. Moreover, further in depth studies should be con-
ducted to assess predictors of MetS and the performance
of the health care system in order to design, and imple-
ment a cost-effective and comprehensive patient care ap-
proach for hypertensive patients.
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